Listings for biosimilar uptake drivers expanded

Amended prescribing information has been released for two biosimilar uptake drivers listed on the Pharmaceutical Benefits Scheme (PBS), as part of the Biosimilar Awareness...

Budget’s funding welcome, but more is needed for pharmacy

PSA has welcomed the government’s commitment to pharmacy in the 2019-20 Federal Budget through the extension of the Administration Handling and Infrastructure (AHI) fee...

Medicine safety: The big picture

Dr Libby Roughead MPS is Senior Principal Research Fellow at the University of South Australia’s School of Pharmacy, where her work focuses on quantifying...

Highlights from PSA19, day one

In case you missed it, here's some of the action from the first day of PSA19 – from the Welcome Reception, Early Career Pharmacists...

Respimat® reusable

The inhaleability* you know, with enhanced handling for patients†1–9  

From the President: Pharmacists’ support valued during 2021

'I would like to take this opportunity to thank you for your valued support during 2021,' writes PSA National President A/Prof Chris Freeman.